Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials.
about
Amantadine and rimantadine for influenza A in children and the elderlyAmantadine and rimantadine for influenza A in children and the elderlyAn overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsN-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's diseaseMemantine: New prospective in bipolar disorder treatmentDementiaDementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.Potential future neuroprotective therapies for neurodegenerative disorders and stroke.Medication for Alzheimer's disease and associated fall hazard: a retrospective cohort study from the Alzheimer's Disease Neuroimaging Initiative.Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.Treatment advances in Alzheimer's disease based on the oxidative stress model.An open-label, multicenter observational study for patients with Alzheimer's disease treated with memantine in the clinical practiceMemantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study.The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover studyUpdate on the use of memantine in Alzheimer's disease.Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer's disease.Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease.Memantine in dementia: a review of the current evidence.The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response.Memantine for the treatment of general neuropathic pain: a narrative review.Cost-effectiveness of memantine in moderate and severe Alzheimer's disease in Norway.Profiling donepezil template into multipotent hybrids with antioxidant properties.High-Performance Liquid Chromatographic Ultraviolet Determination of Memantine Hydrochloride afterIn VitroTransdermal Diffusion Studies
P2860
Q24187883-7C9ABD39-3A00-474A-8295-532204CB281CQ24203853-05BD04E7-34AD-4004-BB4F-35A6A502ABB0Q26751302-F54E8CDE-9D80-49CC-B189-C8F28D01CCACQ26825619-9338AE99-A6BC-4BA4-A064-57086EB4045BQ26852133-367408EC-65FB-4EFE-88DC-C4F6267AE58AQ26860881-D4891E52-7FD6-42D5-881A-A6C9E86A6A8EQ33160127-D1851FB8-04AB-451A-AC0B-161AC159A2A7Q33687436-E9BCA691-123E-4A27-98E0-C0AF64F9D0FCQ33792563-A97E7C71-38BD-4E71-8588-3DE4D6A11CE0Q34084791-69B6CD6D-EC07-4143-BA42-EFC337A1E7BDQ34167375-6BAB63DB-01BE-4948-8808-B299E10A6D61Q35428340-E4B9B06F-8567-48ED-AD5E-208B71C085DEQ36302190-12D98064-54CC-4531-9514-BEE725CFF9FFQ36923575-86CFA9E5-7BC4-4315-8925-3618EA45493CQ37111872-824761E6-65A2-429F-9C7A-F02A1F69D858Q37224558-A886AC8C-FDC4-4703-8E33-57A4F90C1B06Q37411818-C355A553-8472-4B1A-907B-9DCACE9A25AAQ37764347-98FC9C26-FC44-467E-93DC-516C6CEABAC9Q37850821-4850466C-A8DA-4F59-BE32-A9A75DE876B1Q38025454-74045512-A116-441C-8D8B-49F00621396BQ38150922-D41BFF49-369A-47A2-AFFA-7591A5C8D0FDQ43061597-9855E57A-D994-4CC5-BB96-75F61AFF1F10Q51540596-FF0494C0-E050-4AE8-ACB2-D07FC2E0DCFCQ52660268-63320705-D61E-4428-BA50-DDB8E20DFE85Q59008329-60A3C819-5202-428F-BEE1-B59EFC2DDA8B
P2860
Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Memantine for the treatment of ...... ety data from clinical trials.
@ast
Memantine for the treatment of ...... ety data from clinical trials.
@en
type
label
Memantine for the treatment of ...... ety data from clinical trials.
@ast
Memantine for the treatment of ...... ety data from clinical trials.
@en
prefLabel
Memantine for the treatment of ...... ety data from clinical trials.
@ast
Memantine for the treatment of ...... ety data from clinical trials.
@en
P2093
P1433
P1476
Memantine for the treatment of ...... ety data from clinical trials.
@en
P2093
Gustavo Alva
Martin R Farlow
Stephen M Graham
P2860
P304
P356
10.2165/00002018-200831070-00003
P577
2008-01-01T00:00:00Z
P6179
1016769107